切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2021, Vol. 10 ›› Issue (02) : 64 -69. doi: 10.3877/cma.j.issn.2095-3216.2021.02.002

所属专题: 文献

论著

中性粒细胞/淋巴细胞比值对急性肾损伤重症患者预后的评估价值
陈蕾1, 魏丽敏1, 程鑫2, 郭小霞3,(), 蒋红利1,()   
  1. 1. 710061 西安交通大学第一附属医院血液净化科
    2. 710089 西安交通大学第一附属医院东院肾脏内科
    3. 710004 西安市第四医院
  • 收稿日期:2020-07-11 出版日期:2021-04-30
  • 通信作者: 郭小霞, 蒋红利
  • 基金资助:
    国家自然科学基金(81870507)

Value of neutrophil-to-lymphocyte ratio in evaluating prognosis of patients with severe acute kidney injury

Lei Chen1, Limin Wei1, Xin Cheng2, Xiaoxia Guo3,(), Hongli Jiang1,()   

  1. 1. Department of Blood Purification, First Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710061
    2. Department of Nephrology, Eastern Hospital of First Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710089
    3. Xi′an City Fourth Hospital, Xi′an 710004; Shaanxi Province, China
  • Received:2020-07-11 Published:2021-04-30
  • Corresponding author: Xiaoxia Guo, Hongli Jiang
引用本文:

陈蕾, 魏丽敏, 程鑫, 郭小霞, 蒋红利. 中性粒细胞/淋巴细胞比值对急性肾损伤重症患者预后的评估价值[J]. 中华肾病研究电子杂志, 2021, 10(02): 64-69.

Lei Chen, Limin Wei, Xin Cheng, Xiaoxia Guo, Hongli Jiang. Value of neutrophil-to-lymphocyte ratio in evaluating prognosis of patients with severe acute kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(02): 64-69.

目的

探讨中性粒细胞/淋巴细胞比值(NLR)与急性肾损伤(AKI)重症患者90 d死亡风险之间的关系,评估NLR对此类患者预后的预测价值。

方法

回顾性分析2015年1月至2019年12月收治于西安交通大学第一附属医院重症监护病房的802例AKI患者,根据入院初始NLR水平分为低NLR组(NLR<9)及高NLR组(NLR≥9),比较组间基础疾病、初始序贯器官衰竭评分(SOFA)、白细胞(WBC)、中性粒细胞百分比(NEU%)、血红蛋白(Hb)、血小板(PLT)、乳酸(Lac)、pH值、血糖(Glu)、肌酸激酶(CK)、90 d全因死亡情况等变量之间的差异。运用Logistic回归模型分析AKI重症患者90 d死亡的危险因素;绘制受试者工作特征(ROC)曲线,并根据ROC曲线下面积(AUC)评估NLR对AKI重症患者住院90 d死亡风险的预测价值。

结果

两组患者的年龄、性别、AKI分期、Glu差异均无统计学意义;高NLR组患者的SOFA评分、WBC、Neu%、Hb、PLT、BUN、SCr、Lac及CK均高于低NLR组患者,BMI及pH值低于低NLR组患者。相较于低NLR组,高NLR组的90 d死亡率明显升高(32.6% vs 16%,P<0.001)。多因素Logistic回归分析显示,即使校正了年龄、性别、BMI、基础病因素、Lac值、AKI分期以及SOFA评分后,NLR仍是AKI重症患者90 d死亡的独立预测因子(OR=2.402,95%CI:1.633~3.533,P<0.001)。基于传统指标(年龄、性别、BMI、基础疾病、AKI分期、SOFA评分及Lac)的90 d死亡风险基础预测模型AUC为0.761(95%CI:0.730~0.790),而基础模型联合NLR的90 d死亡风险预测模型AUC为0.783(95%CI:0.753~0.811),二者之间的差异具有统计学意义(P=0.0067)。

结论

NLR对AKI重症患者90 d死亡风险具有一定的预测价值,有助于提高基础模型对AKI重症患者90 d死亡风险的预测能力。

Objective

To explore the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the 90-day mortality risk in severe patients with acute kidney injury (AKI), so as to evaluate the predictive value of NLR for the prognosis.

Methods

Retrospective analysis was made in 802 AKI patients who were admitted to the intensive care unit of the First Affiliated Hospital of Xi′an Jiaotong University from January 2015 to December 2019, and divided into low-NLR group (NLR<9) and high-NLR group (NLR≥9) according to the NLR level at admission. Differences were compared between the two groups in the underlying diseases, initial sequential organ failure assessment (SOFA), white blood cells (WBC), neutrophil percentage (NEU%), hemoglobin (Hb), platelet (PLT), lactic acid (Lac), pH, blood glucose (Glu), creatine kinase (CK), 90-day all-cause-death, and other variables. Logistic regression model was used to analyze the risk factors for 90-day mortality in critically ill patients with AKI. The receiver operating characteristic (ROC) curve was drawn, and the area under the ROC curve (AUC) was calculated to evaluate the predictive value of NLR for the 90-day mortality in critically ill patients with AKI.

Results

There was no statistically significant difference in age, gender, ill AKI staging, and Glu between the two groups. In the high-NLR group, the levels of SOFA score, WBC, Neu%, Hb, PLT, BUN, SCr, Lac, and CK were higher, while BMI and pH were lower than those in the low-NLR group. The 90-day mortality rate was significantly higher in the high-NLR group than in the low-NLR group (32.6% vs 16%, P< 0.001). Multivariate logistic regression analysis showed that even after adjustment for age, gender, BMI, underlying disease factors, Lac value, AKI staging, and SOFA score, the NLR was still an independent predictor of 90-day mortality in critically ill patients with AKI (OR=2.402, 95%CI: 1.633-3.533, P<0.001). The AUC of the 90-day mortality risk prediction model based on traditional indicators (age, gender, BMI, underlying diseases, AKI staging, SOFA score, and Lac) was 0.761 (95%CI: 0.730-0.790), while the AUC of the 90-day mortality risk prediction model based on both traditional indicators and NLR was 0.783 (95%CI: 0.753 to 0.811), and the difference between the two models was statistically significant (P=0.0067).

Conclusion

NLR had a certain predictive value for the 90-day mortality risk in critically ill AKI patients, and might help improve the predictive ability of the model based on the traditional indicators.

表1 两组患者的一般资料
表2 两组患者的实验室检查结果
表3 影响AKI重症患者90 d死亡的单因素Logistic回归分析
表4 影响AKI重症患者90 d死亡的多因素Logistic回归分析
图1 急性肾损伤重症患者90 d死亡的2种临床预测模型(基础模型及基础模型联合NLR)的ROC曲线
[1]
Sawhney S, Marks A, Fluck N, et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study [J]. Am J Kidney Dis, 2017, 69(1): 18-28.
[2]
Kaddourah A, Basu RK, Bagshaw SM, et al. Epidemiology of acute kidney injury in critically ill children and young adults [J]. N Engl J Med, 2017, 376(1): 11-20.
[3]
Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury [J]. Nat Rev Nephrol, 2018, 14(10): 607-625.
[4]
Wang HE, Muntner P, Chertow GM, et al. Acute kidney injury and mortality in hospitalized patients [J]. Am J Nephrol, 2012, 35(4): 349-355.
[5]
Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis [J]. Clin Biochem, 2018, 52: 131-136.
[6]
Bonaventura A, Liberale L, Carbone F, et al. Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery [J]. Acta Diabetol, 2019, 56(7): 741-748.
[7]
Mei Z, Shi L, Wang B, et al. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies [J]. Cancer Treat Rev, 2017, 58: 1-13.
[8]
Rabb H, Griffin MD, Mckay DB, et al. Inflammation in AKI: current understanding, key questions, and knowledge gaps [J]. J Am Soc Nephrol, 2016, 27(2): 371-379.
[9]
Bu X, Zhang L, Chen P, et al. Relation of neutrophil-to-lymphocyte ratio to acute kidney injury in patients with sepsis and septic shock: a retrospective study [J]. Int Immunopharmacol, 2019, 70: 372-377.
[10]
陈巧芹. 过敏性紫癜患儿急性肾损伤与中性粒细胞和淋巴细胞比值的相关性[J]. 儿科药学杂志,2019, 25(6): 3-6.
[11]
王利华,苏晓乐. 急性肾损伤的诊断和早期预警[J/CD]. 中华肾病研究电子杂志,2019, 8(4): 145-149.
[12]
Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults [J]. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
[13]
肖力,孙林,刘伏友. 急性肾脏病的病因及发病机制[J/CD]. 中华肾病研究电子杂志,2017, 6(6): 252-258.
[14]
Chen D, Xiao D, Guo J, et al. Neutrophil-lymphocyte count ratio as a diagnostic marker for acute kidney injury: a systematic review and meta-analysis [J]. Clin Exp Nephrol, 2020, 24(2): 126-135.
[15]
Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 [J]. J Infect, 2020, 81(1): e6-e12.
[16]
韩蕊,丛燕,赵澐. 中性粒细胞/淋巴细胞比值在老年脓毒症患者急性肾损伤诊断和预后中的价值[J]. 老年医学与保健,2020, 26(2): 262-265, 273.
[17]
Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer [J]. Crit Rev Oncol Hematol, 2013, 88(1): 218-230.
[18]
Kantola T, Klintrup K, Väyrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma [J]. Br J Cancer, 2012, 107(10): 1729-1736.
[1] 韩圣瑾, 周正武, 翁云龙, 黄鑫. 碳酸氢钠林格液联合连续性肾脏替代疗法对创伤合并急性肾损伤患者炎症水平及肾功能的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 376-381.
[2] 张秋彬, 张楠, 林清婷, 徐军, 朱华栋, 姜辉. 急性胰腺炎合并急性肾损伤患者的预后评估[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 382-389.
[3] 莫小乔, 胡喆莹, 廖冬花, 谢天. 脓毒症继发急性肾损伤患者死亡风险预测模型构建及评估[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 198-206.
[4] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[5] 李青霖, 宋仁杰, 周飞虎. 一种重型劳力性热射病相关急性肾损伤小鼠模型的建立与探讨[J]. 中华肾病研究电子杂志, 2023, 12(05): 265-270.
[6] 任加发, 邬步云, 邢昌赢, 毛慧娟. 2022年急性肾损伤领域基础与临床研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 276-281.
[7] 李金璞, 饶向荣. 抗病毒药物和急性肾损伤[J]. 中华肾病研究电子杂志, 2023, 12(05): 287-290.
[8] 宋艳琪, 任雪景, 王文娟, 韩秋霞, 续玥, 庄凯婷, 肖拓, 蔡广研. 间充质干细胞对顺铂诱导的小鼠急性肾损伤中细胞铁死亡的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 187-193.
[9] 程庆砾. 新冠病毒感染与肾脏[J]. 中华肾病研究电子杂志, 2023, 12(04): 240-240.
[10] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[11] 李娜, 朱国贞. 肠道菌群及其代谢产物在急性肾损伤中的作用研究进展[J]. 中华肾病研究电子杂志, 2023, 12(04): 215-219.
[12] 于天宇, 杨悦, 陆海涛, 田志永, 李文歌. 高龄急性肾损伤患者连续性肾脏替代治疗的预后及影响因素[J]. 中华肾病研究电子杂志, 2023, 12(03): 134-138.
[13] 任国华, 杜晓晓, 洪善玲, 邵帅. 妊娠期高血压并发急性肾损伤患者血清白细胞介素-22、硫化氢及护骨素水平的变化与意义[J]. 中华肾病研究电子杂志, 2023, 12(03): 150-155.
[14] 王蕤, 乔晞. 重症监护室发生急性肾损伤的危险因素[J]. 中华肾病研究电子杂志, 2023, 12(02): 93-96.
[15] 易成, 韦伟, 赵宇亮. 急性肾脏病的概念沿革[J]. 中华临床医师杂志(电子版), 2023, 17(08): 906-910.
阅读次数
全文


摘要